| Product Code: ETC13198243 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Fragment Based Drug Discovery Market was valued at USD 1.2 Billion in 2024 and is expected to reach USD 2 Billion by 2031, growing at a compound annual growth rate of 7.60% during the forecast period (2025-2031).
The Global Fragment Based Drug Discovery Market is experiencing significant growth driven by the increasing demand for novel and effective drug candidates. This approach involves screening small molecule fragments to identify potential drug leads, offering advantages such as faster identification of hits and reduced development costs. The market is characterized by the adoption of advanced technologies such as nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography for fragment screening. Key players in the market are focusing on strategic collaborations and partnerships to expand their product offerings and strengthen their market presence. With the continuous advancements in fragment-based drug discovery technologies and the rising investment in drug development, the market is poised for robust growth in the coming years.
The Global Fragment Based Drug Discovery Market is currently experiencing growth due to the increasing focus on developing novel and more effective drugs. Key trends in the market include the growing adoption of fragment-based screening techniques by pharmaceutical companies, advancements in technology enabling more accurate and efficient screening processes, and the rise in collaborations between research institutions and drug developers. Opportunities in the market lie in the development of personalized medicine, identification of new drug targets, and the potential for addressing complex diseases. With the continuous advancements in technology and the increasing demand for innovative drug discovery solutions, the Global Fragment Based Drug Discovery Market is poised for further expansion in the coming years.
The Global Fragment Based Drug Discovery Market faces several challenges, including limited availability of high-quality fragment libraries, difficulty in identifying and validating fragment hits, and potential issues with compound solubility and potency. Additionally, the complexity of fragment-based screening techniques and the high cost associated with implementing these methods can be barriers for some organizations. Another challenge is the need for specialized expertise and infrastructure to effectively conduct fragment-based drug discovery, which may require significant investment in training and resources. Furthermore, competition within the market and the constant need for innovation to stay ahead in drug discovery further add to the challenges faced by companies operating in this space.
The Global Fragment Based Drug Discovery Market is being primarily driven by the increasing R&D investments in pharmaceutical and biotechnology companies, as well as the growing prevalence of chronic diseases worldwide. Fragment-based drug discovery offers advantages such as improved efficiency, reduced costs, and higher success rates in drug development compared to traditional methods. Additionally, advancements in technologies such as nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography have enhanced the capabilities of fragment-based screening, further fueling market growth. The demand for innovative and effective drugs to address unmet medical needs, coupled with the emphasis on personalized medicine, is also contributing to the expansion of the market for fragment-based drug discovery.
Government policies related to the Global Fragment Based Drug Discovery Market primarily focus on promoting innovation, research, and development in the pharmaceutical sector to address global health challenges. These policies often include funding initiatives, tax incentives, and regulatory frameworks to support the advancement of fragment-based drug discovery technologies. Additionally, government agencies may collaborate with industry stakeholders to encourage partnerships, knowledge sharing, and the translation of research findings into commercial applications. Overall, these policies aim to stimulate investment in drug discovery research, enhance competitiveness in the biopharmaceutical industry, and ultimately improve patient outcomes through the development of novel therapies and treatments.
The Global Fragment Based Drug Discovery Market is expected to witness significant growth in the coming years due to the increasing focus on developing novel and more effective drugs. Factors such as rising prevalence of chronic diseases, growing investment in drug discovery research, and advancements in technology are driving the market expansion. Additionally, the shift towards personalized medicine and the need for targeted therapies are likely to boost the demand for fragment-based drug discovery approaches. The market is also benefiting from collaborations between pharmaceutical companies and research institutions to accelerate drug development processes. However, challenges such as high costs associated with drug discovery and stringent regulatory requirements may hinder market growth to some extent. Overall, the Global Fragment Based Drug Discovery Market is poised for steady growth in the foreseeable future.
In the Global Fragment Based Drug Discovery Market, North America holds the largest share due to the presence of established pharmaceutical and biotechnology companies investing in research and development activities. Europe follows closely behind, fueled by increasing government initiatives and collaborations aimed at advancing drug discovery technologies. In Asia, the market is witnessing rapid growth driven by the rising prevalence of chronic diseases and expanding healthcare infrastructure. The Middle East and Africa region is also showing promising growth potential as governments focus on improving healthcare access and investing in research and development. Latin America is experiencing moderate growth, with increasing investments in the pharmaceutical sector and a growing focus on developing innovative drug discovery solutions to address healthcare challenges in the region.
Global Fragment Based Drug Discovery Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Fragment Based Drug Discovery Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Fragment Based Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Global Fragment Based Drug Discovery Market - Industry Life Cycle |
3.4 Global Fragment Based Drug Discovery Market - Porter's Five Forces |
3.5 Global Fragment Based Drug Discovery Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Fragment Based Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.7 Global Fragment Based Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Fragment Based Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Fragment Based Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Fragment Based Drug Discovery Market Trends |
6 Global Fragment Based Drug Discovery Market, 2021 - 2031 |
6.1 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Fragment Screening, 2021 - 2031 |
6.1.3 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Biophysical Techniques, 2021 - 2031 |
6.1.4 Global Fragment Based Drug Discovery Market, Revenues & Volume, By NMR Spectroscopy, 2021 - 2031 |
6.1.5 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Differential Scanning Fluorimetry (DSF) Assay, 2021 - 2031 |
6.1.6 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Fluorescence Polarization, 2021 - 2031 |
6.1.7 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Isothermal Titration Calorimetry, 2021 - 2031 |
6.1.8 Global Fragment Based Drug Discovery Market, Revenues & Volume, By X-ray Crystallography, 2021 - 2031 |
6.1.9 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021 - 2031 |
6.2 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021 - 2031 |
6.2.4 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.2.5 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.6 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Metabolic Disorders, 2021 - 2031 |
6.2.7 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Inflammation & Autoimmune Diseases, 2021 - 2031 |
6.3 Global Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Academic & Research Institutions, 2021 - 2031 |
6.3.3 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.3.4 Global Fragment Based Drug Discovery Market, Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031 |
7 North America Fragment Based Drug Discovery Market, Overview & Analysis |
7.1 North America Fragment Based Drug Discovery Market Revenues & Volume, 2021 - 2031 |
7.2 North America Fragment Based Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
7.4 North America Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Fragment Based Drug Discovery Market, Overview & Analysis |
8.1 Latin America (LATAM) Fragment Based Drug Discovery Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Fragment Based Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
8.4 Latin America (LATAM) Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Fragment Based Drug Discovery Market, Overview & Analysis |
9.1 Asia Fragment Based Drug Discovery Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Fragment Based Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
9.4 Asia Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Fragment Based Drug Discovery Market, Overview & Analysis |
10.1 Africa Fragment Based Drug Discovery Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Fragment Based Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
10.4 Africa Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Fragment Based Drug Discovery Market, Overview & Analysis |
11.1 Europe Fragment Based Drug Discovery Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Fragment Based Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
11.4 Europe Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Fragment Based Drug Discovery Market, Overview & Analysis |
12.1 Middle East Fragment Based Drug Discovery Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Fragment Based Drug Discovery Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Fragment Based Drug Discovery Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Fragment Based Drug Discovery Market, Revenues & Volume, By Component, 2021 - 2031 |
12.4 Middle East Fragment Based Drug Discovery Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Fragment Based Drug Discovery Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Fragment Based Drug Discovery Market Key Performance Indicators |
14 Global Fragment Based Drug Discovery Market - Export/Import By Countries Assessment |
15 Global Fragment Based Drug Discovery Market - Opportunity Assessment |
15.1 Global Fragment Based Drug Discovery Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Fragment Based Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
15.3 Global Fragment Based Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Fragment Based Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Fragment Based Drug Discovery Market - Competitive Landscape |
16.1 Global Fragment Based Drug Discovery Market Revenue Share, By Companies, 2024 |
16.2 Global Fragment Based Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here